IVA Competitors & Alternatives
Compare Inventiva Sa with similar stocks in the same industry
Biotechnology
IVA
Main Stock$4.68
Tradestie Score
44
Market Cap
$821.84M
Revenue Growth
-0.9%
Analyst Upside
+218.0%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$59.82
|
$1.17B | - | 46 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$21.07
|
$1.15B | 5.0 | 45 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.96
|
$1.14B | - | 53 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$14.20
|
$1.14B | - | 38 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$29.43
|
$1.13B | - | 49 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.29
|
$1.12B | - | 47 | Compare |
|
NKTR
Nektar Therapeutics
|
$74.02
|
$1.12B | - | 51 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$375.94
|
$1.12B | - | 38 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$8.93
|
$1.09B | - | 38 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$11.85
|
$1.05B | 84.6 | 36 | Compare |
More IVA Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry